Chesley Taft & Associates LLC raised its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.9% during the
Category Archives: Uncategorized
BIO Has Big Diversity Goals. Does It Have the Means to Reach Them?
Whether from embarrassing parties or sobering surveys, the biotech gender gap problem has made plenty of headlines the past couple
Drug Importation: Dangerous for Patients, Consumers, and American Communities
Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a simple message to the American
Bioeconomy – A new bioeconomy strategy for a sustainable Europe
[Source: Research & Innovation] Today the Commission has put forward an action plan to develop a sustainable and circular bioeconomy
Swabbing DNA on Phones Reveals Mysteries of Microbial World Around Us
Ask someone “What’s on your phone?” and he or she might respond with some combination of photos, music, contacts, and
Brent Erickson in Biofuels Digest: It’s Past Midnight in America
In 1984, President Ronald Reagan used the phrase “It’s Morning in America” as a now famous campaign message to reassure American’s
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test
The FDA has lifted its hold on a clinical trial for a genetically engineered treatment for sickle cell disease, and
2018 Biocities Forum – 14 November 2018, Barcelona, Spain
[Source: Research & Innovation] The Biocities Forum will facilitate international science-policy-business dialogue on the potential of forests and circular bioeconomy
Eyeing NASH, Glympse Raises $22M to Test Disease Detection Nanotech
Glympse Bio has developed sensor technology that it says can give clinicians an early look at a developing disease. As
Research Headlines – Remote monitoring boost for long-term patients
[Source: Research & Innovation] Patients with long-term medical conditions, such as depression, multiple sclerosis and epilepsy, need regular monitoring, but